PACB · Pacific Biosciences of California Inc. Common Stock
View on chartInsiders & Stakes
| Christian O. Henry Director | ▼ Sell | Open Market | 3,581,813 Shares held | 3/3/2026 | View profile |
| Van Oene Mark Chief Operating Officer | ▼ Sell | Open Market | 2,705,853 Shares held | 8/17/2026 | View profile |
| Gibson James R II See Remarks | ▼ Sell | Open Market | 1,083,848 Shares held | 10/6/2026 | View profile |
| Eidel Jeff See Remarks | ▼ Sell | Open Market | 869,730 Shares held | 8/19/2024 | View profile |
| Kim Susan G. Chief Financial Officer | ▼ Sell | Open Market | 695,654 Shares held | 9/30/2024 | View profile |
| ORDONEZ KATHY Director | ▲ Buy | Grant | 403,037 Shares held | 6/18/2024 | View profile |
| Farmer Michele See Remarks | ▼ Sell | Open Market | 305,948 Shares held | 3/3/2026 | View profile |
| Fromen Peter Chief Commercial Officer | ▲ Buy | Grant | 190,280 Shares held | 3/2/2022 | View profile |
| Marshall Mohr Director | ▲ Buy | Grant | 132,821 Shares held | 6/18/2024 | View profile |
| MILLIGAN JOHN F Director | ▲ Buy | Grant | 132,821 Shares held | 6/18/2024 | View profile |
| Christopher Gibson Chief Executive Officer | ▲ Buy | Grant | 111,386 Shares held | 4/8/2026 | View profile |
| Meline David W Director | ▲ Buy | Grant | 57,116 Shares held | 6/18/2024 | View profile |
| Smith Christopher M Director | ▲ Buy | Grant | 54,099 Shares held | 1/30/2025 | View profile |
| Ericson William W. Director | ▲ Buy | Grant | 41,616 Shares held | 6/18/2024 | View profile |
| Hannah Valantine Director | ▲ Buy | Grant | 22,821 Shares held | 6/18/2024 | View profile |
| LIVINGSTON RANDALL S Director | ▲ Buy | Grant | 22,821 Shares held | 6/18/2024 | View profile |
| Shapiro Lucy Director | ▲ Buy | Grant | 22,821 Shares held | 6/18/2024 | View profile |
Transaction History
| Gibson James R II | ▲ Buy | Option Exercise | 500,000 | $590K | 10/6/2026 |
| Gibson James R II | ▼ Sell | Open Market | 661,815 | $2.1M | 10/6/2026 |
| Van Oene Mark | ▼ Sell | Open Market | 26,911 | $30K | 8/17/2026 |
| Van Oene Mark | ▲ Buy | Grant | 489,130 | $0 | 8/10/2026 |
| Christopher Gibson | ▲ Buy | Grant | 57,473 | $0 | 4/8/2026 |
| Gibson James R II | ▼ Sell | Open Market | 88,185 | $121K | 4/1/2026 |
| Christian O. Henry | ▼ Sell | Open Market | 12,497 | $19K | 3/3/2026 |
| Van Oene Mark | ▼ Sell | Open Market | 6,504 | $10K | 3/3/2026 |
| Farmer Michele | ▼ Sell | Open Market | 2,979 | $5K | 3/3/2026 |
| Christopher Gibson | ▲ Buy | Grant | 53,913 | $0 | 3/3/2026 |
| Christian O. Henry | ▲ Buy | Grant | 920,810 | $0 | 2/27/2026 |
| Van Oene Mark | ▲ Buy | Grant | 500,000 | $0 | 2/27/2026 |
| Gibson James R II | ▲ Buy | Grant | 333,848 | $0 | 2/27/2026 |
| Farmer Michele | ▲ Buy | Grant | 89,835 | $0 | 2/27/2026 |
| Van Oene Mark | ▼ Sell | Open Market | 55,107 | $90K | 2/18/2026 |
| Christian O. Henry | ▼ Sell | Open Market | 140,874 | $229K | 2/18/2026 |
| Farmer Michele | ▼ Sell | Open Market | 14,952 | $24K | 2/18/2026 |
| Van Oene Mark | ▼ Sell | Open Market | 129,790 | $205K | 2/17/2026 |
| Christian O. Henry | ▼ Sell | Open Market | 331,793 | $523K | 2/17/2026 |
| Farmer Michele | ▼ Sell | Open Market | 35,215 | $55K | 2/17/2026 |
| Van Oene Mark | ▼ Sell | Open Market | 26,836 | $35K | 8/18/2025 |
| Farmer Michele | ▼ Sell | Open Market | 5,195 | $5K | 5/19/2025 |
| Gibson James R II | ▲ Buy | Grant | 1,000,000 | $0 | 3/31/2025 |
| Farmer Michele | ▲ Buy | Grant | 89,835 | $0 | 3/19/2025 |
| Christian O. Henry | ▲ Buy | Grant | 920,810 | $0 | 3/19/2025 |
| Van Oene Mark | ▲ Buy | Grant | 449,176 | $0 | 3/19/2025 |
| Van Oene Mark | ▼ Sell | Open Market | 6,486 | $9K | 3/3/2025 |
| Farmer Michele | ▼ Sell | Open Market | 2,973 | $4K | 3/3/2025 |
| Christian O. Henry | ▼ Sell | Open Market | 12,497 | $18K | 3/3/2025 |
| Farmer Michele | ▼ Sell | Open Market | 24,349 | $46K | 2/18/2025 |
| Van Oene Mark | ▼ Sell | Open Market | 100,773 | $189K | 2/18/2025 |
| Christian O. Henry | ▼ Sell | Open Market | 259,909 | $488K | 2/18/2025 |
| Smith Christopher M | ▲ Buy | Grant | 54,099 | $0 | 1/30/2025 |
| Van Oene Mark | ▼ Sell | Open Market | 34,405 | $70K | 1/10/2025 |
| Kim Susan G. | ▼ Sell | Open Market | 19,782 | $34K | 9/30/2024 |
| Christian O. Henry | ▼ Sell | Open Market | 98,907 | $173K | 9/16/2024 |
| Eidel Jeff | ▼ Sell | Open Market | 26,760 | $43K | 8/19/2024 |
| Van Oene Mark | ▼ Sell | Open Market | 38,011 | $63K | 8/16/2024 |
| Meline David W | ▲ Buy | Grant | 17,116 | $0 | 6/18/2024 |
| Hannah Valantine | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| MILLIGAN JOHN F | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| ORDONEZ KATHY | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| Shapiro Lucy | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| Marshall Mohr | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| LIVINGSTON RANDALL S | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| Ericson William W. | ▲ Buy | Grant | 22,821 | $0 | 6/18/2024 |
| Farmer Michele | ▼ Sell | Open Market | 5,275 | $11K | 5/20/2024 |
| ORDONEZ KATHY | ▲ Buy | Option Exercise | 324,515 | $941K | 3/15/2024 |
| ORDONEZ KATHY | ▲ Buy | Option Exercise | 37,106 | $98K | 3/15/2024 |
| Meline David W | ▲ Buy | Open Market | 40,000 | $176K | 3/6/2024 |
| Farmer Michele | ▼ Sell | Open Market | 2,968 | $14K | 3/4/2024 |
| Van Oene Mark | ▼ Sell | Open Market | 9,186 | $45K | 3/4/2024 |
| Kim Susan G. | ▼ Sell | Open Market | 5,275 | $26K | 3/4/2024 |
| Christian O. Henry | ▼ Sell | Open Market | 14,177 | $69K | 3/4/2024 |
| Marshall Mohr | ▲ Buy | Option Exercise | 25,000 | $111K | 3/1/2024 |
| Christian O. Henry | ▲ Buy | Grant | 1,605,769 | $0 | 2/22/2024 |
| Van Oene Mark | ▲ Buy | Grant | 798,076 | $0 | 2/22/2024 |
| Kim Susan G. | ▲ Buy | Grant | 432,692 | $0 | 2/22/2024 |
| Eidel Jeff | ▲ Buy | Grant | 461,538 | $0 | 2/22/2024 |
| Farmer Michele | ▲ Buy | Grant | 115,384 | $0 | 2/22/2024 |
| Kim Susan G. | ▼ Sell | Open Market | 831 | $4K | 2/20/2024 |
| Christian O. Henry | ▼ Sell | Open Market | 1,979 | $10K | 2/20/2024 |
| Van Oene Mark | ▼ Sell | Open Market | 33,560 | $200K | 2/16/2024 |
| Eidel Jeff | ▼ Sell | Open Market | 15,498 | $92K | 2/16/2024 |
| Kim Susan G. | ▼ Sell | Open Market | 22,496 | $134K | 2/16/2024 |
| Christian O. Henry | ▼ Sell | Open Market | 79,038 | $471K | 2/16/2024 |
| Farmer Michele | ▼ Sell | Open Market | 7,562 | $45K | 2/16/2024 |
| Van Oene Mark | ▼ Sell | Open Market | 31,012 | $241K | 1/9/2024 |
| Christian O. Henry | ▼ Sell | Open Market | 20,000 | $200K | 12/14/2023 |
| Kim Susan G. | ▼ Sell | Open Market | 19,257 | $162K | 9/29/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 96,844 | $980K | 9/18/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 10,000 | $105K | 9/11/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 10,000 | $105K | 8/17/2023 |
| Eidel Jeff | ▼ Sell | Open Market | 25,936 | $275K | 8/17/2023 |
| Van Oene Mark | ▼ Sell | Open Market | 26,102 | $287K | 8/16/2023 |
| Marshall Mohr | ▲ Buy | Option Exercise | 25,000 | $64K | 5/18/2023 |
| Farmer Michele | ▼ Sell | Open Market | 5,165 | $65K | 5/18/2023 |
| Ericson William W. | ▼ Sell | Open Market | 7,541 | $67K | 3/15/2023 |
| Ericson William W. | ▲ Buy | Option Exercise | 25,000 | $64K | 3/15/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 13,769 | $131K | 3/3/2023 |
| Kim Susan G. | ▼ Sell | Open Market | 5,045 | $48K | 3/3/2023 |
| Van Oene Mark | ▼ Sell | Open Market | 6,268 | $60K | 3/3/2023 |
| Farmer Michele | ▼ Sell | Open Market | 3,153 | $30K | 3/3/2023 |
| Kim Susan G. | ▲ Buy | Grant | 164,200 | $0 | 3/2/2023 |
| Christian O. Henry | ▲ Buy | Grant | 594,687 | $0 | 3/2/2023 |
| Farmer Michele | ▲ Buy | Grant | 52,100 | $0 | 3/2/2023 |
| Eidel Jeff | ▲ Buy | Grant | 164,200 | $0 | 3/2/2023 |
| Van Oene Mark | ▲ Buy | Grant | 328,500 | $0 | 3/2/2023 |
| Kim Susan G. | ▼ Sell | Open Market | 907 | $9K | 2/17/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 1,530 | $16K | 2/17/2023 |
| Van Oene Mark | ▼ Sell | Open Market | 26,722 | $255K | 1/10/2023 |
| Christian O. Henry | ▼ Sell | Open Market | 45,000 | $488K | 12/1/2022 |
| Kim Susan G. | ▼ Sell | Open Market | 12,968 | $73K | 9/29/2022 |
| Christian O. Henry | ▼ Sell | Open Market | 91,307 | $527K | 9/15/2022 |
| Van Oene Mark | ▲ Buy | Grant | 300,000 | $0 | 8/25/2022 |
| Eidel Jeff | ▲ Buy | Grant | 300,000 | $0 | 8/16/2022 |
| Marshall Mohr | ▲ Buy | Option Exercise | 35,000 | $64K | 6/10/2022 |
| Farmer Michele | ▼ Sell | Open Market | 3,573 | $20K | 5/18/2022 |
| Ericson William W. | ▼ Sell | Other | 1,268 | — | 3/17/2022 |
| Ericson William W. | ▼ Sell | Other | 4,848,397 | — | 3/17/2022 |
| Kim Susan G. | ▲ Buy | Grant | 40,000 | $0 | 3/2/2022 |
| Farmer Michele | ▲ Buy | Grant | 22,500 | $0 | 3/2/2022 |
| Fromen Peter | ▲ Buy | Grant | 50,000 | $0 | 3/2/2022 |
| Van Oene Mark | ▲ Buy | Grant | 72,500 | $0 | 3/2/2022 |
| Christian O. Henry | ▲ Buy | Grant | 107,500 | $0 | 3/2/2022 |
| Christian O. Henry | ▼ Sell | Open Market | 2,122 | $24K | 2/17/2022 |
| Kim Susan G. | ▼ Sell | Open Market | 1,062 | $12K | 2/17/2022 |
| ORDONEZ KATHY | ▼ Sell | Open Market | 3,280 | $38K | 2/16/2022 |
| Marshall Mohr | ▲ Buy | Option Exercise | 25,000 | $89K | 1/14/2022 |
| Van Oene Mark | ▼ Sell | Open Market | 41,480 | $590K | 1/11/2022 |
| Fromen Peter | ▼ Sell | Open Market | 19,720 | $282K | 1/11/2022 |
| Kim Susan G. | ▼ Sell | Open Market | 20,272 | $522K | 9/29/2021 |
| Christian O. Henry | ▼ Sell | Open Market | 90,520 | $2.4M | 9/16/2021 |
| Ericson William W. | ▼ Sell | Other | 68 | — | 2/12/2021 |
| Ericson William W. | ▼ Sell | Other | 750,000 | — | 2/12/2021 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
PACB Pushes HiFi Sequencing for Clinical Growth
Pacific Biosciences is focusing on its HiFi sequencing technology to drive clinical adoption and achieve $40 million in savings. This strategic push aims to address the company's ongoing profitability challenges while targeting long-term growth. The stock recently saw a volume spike and touched its 200-day moving average, reflecting heightened market interest in these operational updates.
PACB Pushes HiFi Sequencing for Clinical Growth. Pacific Biosciences is focusing on its HiFi sequencing technology to drive clinical adoption and achieve $40 million in savings. This strategic push aims to address the company's ongoing profitability challenges while targeting long-term growth. The stock recently saw a volume spike and touched its 200-day moving average, reflecting heightened market interest in these operational updates.